Larissa Lapteva

939 total citations
15 papers, 685 citations indexed

About

Larissa Lapteva is a scholar working on Molecular Biology, Rheumatology and Genetics. According to data from OpenAlex, Larissa Lapteva has authored 15 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Rheumatology and 5 papers in Genetics. Recurrent topics in Larissa Lapteva's work include Systemic Lupus Erythematosus Research (5 papers), Prenatal Screening and Diagnostics (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Larissa Lapteva is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Prenatal Screening and Diagnostics (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Larissa Lapteva collaborates with scholars based in United States, United Kingdom and Germany. Larissa Lapteva's co-authors include Gabor G. Illei, Peter E. Lipsky, Elizabeth Kozora, Christopher M. Filley, John G. Hanly, Miroslawa Nowak, Kazuki Takada, Joseph Bleiberg, Bruce T. Volpe and Cheryl Yarboro and has published in prestigious journals such as Nature Reviews Drug Discovery, JAMA Pediatrics and Obstetrical & Gynecological Survey.

In The Last Decade

Larissa Lapteva

14 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Larissa Lapteva United States	11	423	327	121	120	92	15	685
Zhanyun Da China	16	413 1.0×	261 0.8×	192 1.6×	46 0.4×	35 0.4×	36	775
Yair Levy Israel	13	397 0.9×	222 0.7×	63 0.5×	81 0.7×	95 1.0×	37	667
Yoshiyuki Arinuma Japan	15	589 1.4×	367 1.1×	121 1.0×	200 1.7×	252 2.7×	50	868
Thorsten Krieger Germany	11	252 0.6×	311 1.0×	110 0.9×	129 1.1×	80 0.9×	20	778
Hilda Fragoso-Loyo Mexico	14	703 1.7×	452 1.4×	111 0.9×	223 1.9×	201 2.2×	28	944
Ariel Stock United States	20	663 1.6×	551 1.7×	285 2.4×	108 0.9×	213 2.3×	31	1.3k
Jukka Loukkola Finland	6	722 1.7×	299 0.9×	110 0.9×	141 1.2×	332 3.6×	7	828
A. Wright United States	13	176 0.4×	358 1.1×	206 1.7×	32 0.3×	28 0.3×	31	909
Helga Westerlind Sweden	16	348 0.8×	207 0.6×	118 1.0×	81 0.7×	70 0.8×	54	877
Suhail Aamar Israel	16	168 0.4×	194 0.6×	282 2.3×	17 0.1×	36 0.4×	27	786

Countries citing papers authored by Larissa Lapteva

Since Specialization

Citations

This map shows the geographic impact of Larissa Lapteva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larissa Lapteva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larissa Lapteva more than expected).

Fields of papers citing papers by Larissa Lapteva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larissa Lapteva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larissa Lapteva. The network helps show where Larissa Lapteva may publish in the future.

Co-authorship network of co-authors of Larissa Lapteva

This figure shows the co-authorship network connecting the top 25 collaborators of Larissa Lapteva. A scholar is included among the top collaborators of Larissa Lapteva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larissa Lapteva. Larissa Lapteva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Jonker, Anneliene Hechtelt, David Dimmock, Alison Bateman-House, et al.. (2025). From roadmap to a sustainable end-to-end individualized therapy pathway. PubMed. 6. 941248964–941248964. 1 indexed citations

Jonker, Anneliene Hechtelt, Holm Graeßner, David Dimmock, et al.. (2024). The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap. Nature Reviews Drug Discovery. 24(1). 40–56. 10 indexed citations

Almeida‐Porada, Graça, Anna L. David, Nalin Gupta, et al.. (2022). Prenatal Somatic Cell Gene Therapies: Charting a Path Toward Clinical Applications (Proceedings of the CERSI‐FDA Meeting). The Journal of Clinical Pharmacology. 62(S1). S36–S52. 13 indexed citations

O’Connell, Amy E., Stephanie Guseh, Larissa Lapteva, et al.. (2021). Gene and Stem Cell Therapies for Fetal Care: A Review. Obstetrical & Gynecological Survey. 76(3). 129–131. 1 indexed citations

Lapteva, Larissa, et al.. (2020). Clinical Development of Gene Therapies: The First Three Decades and Counting. Molecular Therapy — Methods & Clinical Development. 19. 387–397. 36 indexed citations

O’Connell, Amy E., Stephanie Guseh, Larissa Lapteva, et al.. (2020). Gene and Stem Cell Therapies for Fetal Care. JAMA Pediatrics. 174(10). 985–985. 11 indexed citations

Lapteva, Larissa, et al.. (2018). Regenerative Medicine Therapies for Rare Diseases. PubMed. 3(3-4). 121–132. 11 indexed citations

Lapteva, Larissa & Anne Pariser. (2016). Investigational New Drug Applications: A 1-Year Pilot Study on Rates and Reasons for Clinical Hold. Journal of Investigative Medicine. 64(2). 376–382. 9 indexed citations

Lapteva, Larissa. (2015). The iron deficiency and helicobacter pylori infection in children. Siberian medical review. 24–29. 1 indexed citations

10.

Kavanaugh, Arthur, John J. Cush, Mahmoud Ahmed, et al.. (2014). Proceedings From the American College of Rheumatology Reproductive Health Summit: The Management of Fertility, Pregnancy, and Lactation in Women With Autoimmune and Systemic Inflammatory Diseases. Arthritis Care & Research. 67(3). 313–325. 61 indexed citations

11.

Kozora, Elizabeth, John G. Hanly, Larissa Lapteva, & Christopher M. Filley. (2008). Cognitive dysfunction in systemic lupus erythematosus: Past, present, and future. Arthritis & Rheumatism. 58(11). 3286–3298. 76 indexed citations

12.

Lapteva, Larissa, Miroslawa Nowak, Cheryl Yarboro, et al.. (2006). Anti–N‐methyl‐D‐aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis & Rheumatism. 54(8). 2505–2514. 190 indexed citations

13.

Roebuck‐Spencer, Tresa, Cheryl Yarboro, Miroslawa Nowak, et al.. (2006). Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus. Arthritis Care & Research. 55(3). 434–441. 58 indexed citations

14.

Illei, Gabor G., et al.. (2004). Biomarkers in systemic lupus erythematosus: I. General overview of biomarkers and their applicability. Arthritis & Rheumatism. 50(6). 1709–1720. 88 indexed citations

15.

Illei, Gabor G., et al.. (2004). Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis & Rheumatism. 50(7). 2048–2065. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact